Historical and Contemporary Clinical Aspects of Transcatheter Aortic Valve Implantation
A.N. Molchanov, E.M. Idov, A.V. Kondrashov, S.D. Chernyshov, L.V. Kardapoltsev, N.A. Lipskaja
pp. 134-146
Ural State Medical University, Yekaterinburg, Russian Federation;
Center for Heart and Vascular them. M.S. Savichevskogo
GBUZ SR «Sverdlovsk Regional Clinical Hospital №1», Yekaterinburg, Russian Federation
DOI: 10.22138/2500-0918-2016-14-2-134-146
Abstract. Aortic stenosis — one of the most common acquired heart disease in the absence of adequate correction leading to disability and death of patients. Available in the arsenal of surgical techniques open surgical correction of the defect are highly effective, but studies show that about 30% of patients are not able to move this operation, due to a number of reasons to take them at high risk. As an alternative method for the treatment of these patients has been proposed a technique of transcatheter aortic valve implantation (TAVI). Recently, a technique is booming and discussed in the literature. In the Russian Federation, certified and used in the clinic valve prostheses Edwards SAPIENS XT (Edwards Lifescience), and MEDTRONIC CoreValve (Medtronic Inc.).
Кeywords: transcatheter aortic valve implantation (TAVI), aortal stenosis, surgical treatment aortic valve
REFERENCE
1. Aminian A., Lalmand J., Dolatabadi D. Late contained aortic root rupture and ventricular septal defect after transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 2013; 81: E72.
2. Barbash I.M., Dvir D., Ben-Dor I. et al. Prevalence and effect of myocardial injury after transcatheter aortic valve replacement. Am. J. Cardiol. 2013; 111: 1337.
3. Binder R.K., Webb J.G., Toggweiler S. et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc.Interv.2013; 6: 462
4. Walther T., Hamm C.W., Schuler G., Berkowitsch A., Kotting J., Mangner N. et al. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J. Am. Coll. Cardiol. 2015; 65: 2173–80.
5. Davies H. Catheter-mounted valve for temporary relief of aortic insufficiency. Lancet, 285 (1965), p. 250.
6. Coscrove D.M. [et al.] A compliant biological endovascular prosthesis. Int. J. Artif. Organs. 1993. Vol. 16. P. 141-145.
7. Cribier A. Development of transcatheter aortic valve implantation (TAVI): A 20-year odyssey Implantation de valves aortiques par voiepercutanee: uneodyssee de 20 ans. Archives of Cardiovascular Diseases. Volume 105, Issue 3, March 2012, Pages 146–152.
8. Alekyan B. G., Pursanov M. G., Kim A.I., etc. Balloon valvuloplastika of a valvate stenosis of an aorta. The bulletin NT SSK imeni A. N. Bakuleva, 2009
9. Ducrocq G., Francis F., Serfaty J.M., et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. Euro Intervention, 5 (2010), pp. 666–672.
10. Himbert D., Descoutures F., Al-Attar N., et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol, 54 (2009), pp. 303–311.
11. Webb J.G., Pasupati S., Humphries K., Thompson C., Altwegg L., Moss R., Sinhal A.,Carere R.G.,Munt B., Ricci D., Ye J., Cheung A., Lichtenstein S.V. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755–763
12. Kahlert P., Knipp S.C., Schlamann M., et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation, 121 (2010), pp. 870–878.
13. Rodes-Cabau J., Webb J.G., Cheung A., et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol, 55 (2010), pp. 1080–1090.
14. Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006–3008.
15. Moreno R., Dobarro D., Lopez de Sa E., et al. Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study Circulation, 120 (2012), pp. e29–e30.
16. Sinhal A., Altwegg L., Pasupati S., et al. Atrioventricular block after transcatheter balloon-expandable aortic valve implantation. JACC Cardiovasc Interv, 1 (2010), pp. 305–309.
17. Webb J., Gerosa G., Lefe` vre T. et al. Multicenter Evaluation of a Next-Generation Balloon-Expandable Transcatheter Aortic Valve. J. Am. Coll. Cardiol. 2014; 64 (21): 2244–5.
18. Martin B. Leon, M.D., Craig R. Smith, M.D. et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosisin Patients Who Cannot Undergo Surgery. The new England journal of medicine, 2010 vol. 363 no. 17 1597-1607.
19. Wenaweser P., Stortecky S., Schwander S. et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur. Heart J. 2013; 34: 1894.
20. Charlson E, Legedza A.T., Hamel M.B. Decision-making and outcomes in severesymptomatic aortic stenosis. J Heart Valve Dis 2010;15:312–321.
21. Cribier A., Litzler P.Y., Eltchaninoff H. Technique of transcatheter aortic valve implantation with the Edwards-Sapien heart valve using the transfemoral approach. Herz. 2009. — V. 34. — P. 347-356.
22. Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Barwolf C., LevangO.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., Vahanian A.A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. EuroHeart J 2013;24:1231–1243.
23. Ludman P.F. British Cardiovascular Intervention Society audit returns: adult interventional procedures Jan 2009 to Dec 2009. BCIS Meeting; 2010 Oct: Cardiff, Wales.
24. Tchetche D., Dumonteil N., Sauguet A., et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population Euro Intervention, 5 (2010), pp. 659–665.
25. Nkomo V.T., Gardin J.M., Skelton T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 2012; 368: 1005-1011.
26. Dvir D., Webb J.G., Bleiziffer S. et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA.2014; 312: 162–70.
27. Abdel-Wahab M., Mehilli J., Frerker C. et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014; 311: 1503.
28. Adams D.H., Popma J.J., Reardon M.J. et al. Transcatheter aortic-valve replacement with self-expanding prosthesis. N. Engl. J. Med. 2014; 370: 1790.
29. Ternovoy S. K., Nikonov M. E., Veselova T.N., Imayev T.E., Komlev A.E., Akchurin R. S., Fedotenkov I.S., Shariya M. A. MSKT in planning of transkateterny prosthetics of the aortal valve. Russian Electronic Journal of Radiology 2013; No. 3. pp. 43-49.
30. Kovalyova E.E. Transkateternaya implantation of the aortal valve and endovascular procedures on coronary arteries. What initially? International magazine of intervention cardiology, 2013; No. 32. pp. 42-43.
31. Hayashida K., Morice M.C., Chevaller B., et al. Sex-related differences in clinical presentation and outcome of TAVI for severe aortic stenosis. J. Am. Coll. Cardiol., 2012, 59, 566-571.
32. D'Agostino R.B., Grundy S., Sullivan L.M., Willson P.W., For the CHD. Risk Prediction Group of the Framingham risk prediction scores. Results of a multiple ethnic group investigation. JAMA 2011; 286:180&7.
33. Egorov I. V. «Senile» heart disease: truth and myths. Lech. Doctor; 2010: 32-36.
34. Lefevre T. [et al.] One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. European Heart Journal. 2011. Vol. 32. P 148-157.
35. Protopopov A.V. Ploshchad of an effective opening as predictor of results surgical лечения.//International magazine of intervention cardiology, 2014; No. 32. Page 42-43.
36. Bruschi G., De Marco F., Fratto P. Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience. Eur. J. Cardiothrac. Surg. 2011. Vol. 39. pp. 151-158.
37. Buellesfeld L., Gerckens U., Schuler G., et al. 2 and year follow and up of patients undergoing transcatheter aortic valve implantation using a selfand expanding valve prosthesis. //J Am Coll Cardiol. 2011; 57:16507.
38. Santini F. [et al.] Over Twenty-Year Follow-Up of the Standard Hancock Porcine Bioprosthesis Implanted in the Mitral Position. Ann. Thorac. Surg. 2014.Vol. 71. P. S232-S235.
39. D’Errigo P., Marco B., Francesco S. Risultatidello studio OBSERVANT: caratteristiche cliniche edesiti a brevetermine della popolazione arruolata sotto posta a sostituzione valvolareaortica (transcatetere versus chirurgica). ITAL CARDIOL .VOL 15, MARZO 2014. 177-184.
40. Bokeria L.A., Alekyan B. G., Podzolkov V.P. Endovaskulyarnaya and minimum invasive surgery of heart and сосудов. Moscow. 2010., 320.
41. Kudryavtseva Yu.A., Nasonova M. V., Glushkov T.V., Akentyeva T.N., Burago A.Yu. Aspects of two years' application transkateternykh of aortal bioartificial limbs. Siberian medical magazine, 2013; No. 5. pp. 1-5.
42. Imayev T.E., Komlev A.E., Akchurin R. S. Transkatetornaya implantation of the aortal valve. A condition of a problem, prospect in Russia. Rational Pharmacotherapy in cardiology of 2015; 11(1): 53-9.
43. Mark M.J., et al. Health and related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2013;124:1964&72
44. Nuis R.J., et al. Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention. Ann. Thorac. Surg. 2011.Vol. 79. P. 1072-1080. pp. 838-845.
45. Bruschi G., Fratto P., De Marco F. The trans-subclavian retrograde approach for transcatheter aortic valve replacement: single center experience. J. thorac. Cardiovasc.Surg. 2010. Vol. 140. pp. 911-915.
Authors
Molchanov Andrey N.
Ural State Medical University
GBUZ SO of «No. 1 SOKB» of Yekaterinburg
MD, the assistant to department warmly-vascular surgery of SEI VPO UGMU, the doctor warmly-vascular surgeon of GBUZ SO of «No. 1 SOKB» of Yekaterinburg molchanov@okb1.ru
amolchanov432@gmail.com
Idov Eduard M.
Ural State Medical University
PhD, MD, manager departments warmly-vascular surgery of SEI VPO UGMU, the chief non-staff specialist of the Ministry of Health of Sverdlovsk region on warmly -vascular surgery
idov@okb1.ru
Кondrashov Аlexander V.
Sverdlovsk regional clinical hospital №1
the doctor warmly-vascular surgeon
siebrn@ya.ru
Chernyshev Sergey D.
Sverdlovsk regional clinical hospital №1
Manager, office of X-ray surgical methods of diagnostics and treatment
Kardapoltsev Lev V.
Sverdlovsk regional clinical hospital №1
The chief non-staff specialist of the Ministry of Health of Sverdlovsk region by X-ray surgical methods of diagnostics and treatment.
Doctor X-ray surgeon of GBUZ SO of «No. 1 SOKB» of Yekaterinburg
Lvkard@mail.ru
Lipskaya Nadezhda A.
Sverdlovsk regional clinical hospital №1
cardiologist
ms.lipskaya@inbox.ru
Ural State Medical University
Sverdlovsk Region, Yekaterinburg, Repin St. 3, 620028 Russian Federation
Center of heart and vessels of M. S. Savichevsky, State budgetary institution of health care of Sverdlovsk region «Sverdlovsk regional clinical hospital No. 1»
Sverdlovsk Region, Yekaterinburg, Volgogradskaya St. 185, 620102 Russian Federation
Received – 28.03.2016
For citation:
Molchanov A.N., Idov E.M., Kondrashov A.V., Chernyshov S.D., Kardapoltsev L.V., Lipskaja N.A. Historical and Contemporary Clinical Aspects of Transcatheter Aortic Valve Implantation [Istoricheskie I sovremennye klinicheskie aspekty transkatetornoj implantatsii aortal’nogo klapana] Vestnik uralskoi meditsinskoi akad-emicheskoi nauki – Vestn. Ural. Med. Akad. Nauki. 2016, no. 2, pp. 134-146. DOI: 10.22138/2500-0918-2016-14-2-134-146 [In Russ.]